{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:30:36Z","timestamp":1771486236917,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2015 Id.17413"],"award-info":[{"award-number":["IG 2015 Id.17413"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2015"],"award-info":[{"award-number":["PRIN 2015"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.10.031","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T15:52:58Z","timestamp":1539791578000},"page":"399-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M.\u00a0tuberculosis DNA gyrase"],"prefix":"10.1016","volume":"161","author":[{"given":"Antonio","family":"Carta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1383-857X","authenticated-orcid":false,"given":"Irene","family":"Briguglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Molicotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Laurini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Aulic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Fermeglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Pricl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.10.031_bib1","series-title":"WHO Global Tuberculosis Report","year":"2017"},{"key":"10.1016\/j.ejmech.2018.10.031_bib2","first-page":"18","article-title":"Tuberculosis is a fatal disease among some developing countries of the world","volume":"3","author":"Mohajan","year":"2015","journal-title":"Am. J. Infect. Dis. Microbiol."},{"key":"10.1016\/j.ejmech.2018.10.031_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","article-title":"The impact of migration on tuberculosis epidemiology and control in high-income countries: a review","volume":"14","author":"Pareek","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2018.10.031_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/eurpub\/cku208","article-title":"Tuberculosis among migrant populations in the european union and the european economic area","volume":"25","author":"Odone","year":"2015","journal-title":"Eur. J. Publ. Health"},{"key":"10.1016\/j.ejmech.2018.10.031_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/092986706775527965","article-title":"Fluoroquinolones: an important class of antibiotics against tuberculosis","volume":"13","author":"Nora De Souza","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"1\u201319","key":"10.1016\/j.ejmech.2018.10.031_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/molecules21040268","article-title":"The current case of quinolones: synthetic approaches and antibacterial activity","volume":"21","author":"Naeem","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.10.031_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/33.4.685","article-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala","year":"1994","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.10.031_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.10.031_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20130430","article-title":"Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes","volume":"455","author":"Bouge","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2018.10.031_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.ejmech.2018.10.031_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2018.04.059","article-title":"New developments in non-quinolone-based antibiotics for the inhibition of bacterial gyrase and topoisomerase IV","volume":"125","author":"Badshah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib12","first-page":"1001","article-title":"1,2,3-Triazolo[4,5-h]quinolines. III. Preparation and anti-microbial evaluation of 4-ethyl-4,7-dihydro-1(2)-R-1(2)-H triazolo[4,5-h]-quinolin-7-one-6-carboxylic acids as anti-infectives of the urinary tract","volume":"47","author":"Sanna","year":"1992","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2018.10.031_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0223-5234(02)01346-6","article-title":"Novel substituted quinoxaline 1,4-dioxides with in\u00a0vitro antimycobacterial and anticandida activity","volume":"37","author":"Carta","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2003.11.008","article-title":"Synthesis, anti-mycobacterial anti-trichomonas and anti-candida in\u00a0vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides","volume":"39","author":"Carta","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2004.11.003","article-title":"In\u00a0vitro activity of new quinoxaline 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria","volume":"25","author":"Zanetti","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2018.10.031_bib16","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/j.bmcl.2007.06.064","article-title":"[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains","volume":"17","author":"Carta","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.10.031_bib17","first-page":"134","article-title":"Anti-mycobacterial activity of quinolones. Triazoloquinolones a new class of potent anti-mycobacterial agents","volume":"7","author":"Carta","year":"2008","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.ejmech.2018.10.031_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2010.11.020","article-title":"Synthesis and anti-mycobacterial activities of triazoloquinolones","volume":"46","author":"Carta","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib19","first-page":"75","article-title":"SAR and anti-mycobacterial activity of quinolones and triazoloquinolones: an update","author":"Briguglio","year":"2013","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.ejmech.2018.10.031_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/jo01254a027","article-title":"The synthesis of some fluoronitrobenzimidazoles and their reactivities toward peptide nucleophiles","volume":"34","author":"Kirk","year":"1969","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3987\/COM-01-9189","article-title":"13C-NMR as useful tool for unambiguous identification of ring substituted N1(2)(3)-alkylbenzotriazole isomers","volume":"55","author":"Carta","year":"2001","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2018.10.031_bib22","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.10.031_bib23","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2018.10.031_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.002","article-title":"Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives","volume":"105","author":"Briguglio","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejmech.2016.03.080","article-title":"A\u00a0combined in silico\/in\u00a0vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems","volume":"117","author":"Carta","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejmech.2017.09.065","article-title":"Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: synthesis, in\u00a0vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics","volume":"141","author":"Briguglio","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib28","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase\u2013fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2018.10.031_bib29","unstructured":"D.A. Case, D.S. Cerutti, T.E. III; Cheatham, T.A. Darden, R.E. Duke, T.J. Giese, H. Gohlke, A.W. Goetz, D. Greene, N. Homeyer, S. Izadi, A. Kovalenko, T.S. Lee, S. LeGrand, P. Li, C. Lin, J. Liu, T. Luchko, R. Luo, D. Mermelstein, K.M. Merz, G. Monard, H. Nguyen, I. Omelyan, A. Onufriev, F. Pan, R. Qi, D.R. Roe, A. Roitberg, C. Sagui, C.L. Simmerling, W.M. Botello-Smith, J. Swails, R.C. Walker, J. Wang, R.M. Wolf, X. Wu, L. Xiao, D.M. York, P.A. Kollman, AMBER 2017 University of California, San Francisco, 2017."},{"key":"10.1016\/j.ejmech.2018.10.031_bib30","first-page":"2785","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity","volume":"16","author":"Morris","year":"2016","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.10.031_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect. Drug Discov."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:49:47Z","timestamp":1759326587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418308997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":31,"alternative-id":["S0223523418308997"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.031","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M.\u00a0tuberculosis DNA gyrase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}